CJC-1295
Also known as: Modified GRF 1-29, DAC:GRF
CJC-1295 is a synthetic analog of growth hormone releasing hormone (GHRH) that stimulates the pituitary gland to release growth hormone. It exists in two forms: with DAC (Drug Affinity Complex) for extended half-life, or without DAC for shorter duration. The peptide is popular in anti-aging and bodybuilding communities for its ability to increase GH levels, potentially improving body composition, recovery, and sleep quality.
Growth hormone releasing hormone (GHRH) analog that stimulates pituitary gland to produce more growth hormone
| Parameter | Detail |
|---|---|
| Administration | Subcutaneous injection |
| Typical Dose | 1-2mg twice weekly (with DAC) |
| Frequency | Twice weekly |
Common Side Effects
Serious Side Effects
- Active cancer
- Pituitary tumors
- Pregnancy
- Children
Evidence Quality
Clinical Trial Phase
Preclinical / Not submitted
| Peptide | Monthly Cost | FDA Status |
|---|---|---|
| CJC-1295 | $35 - $70/mo | Category 2 (pending reclassification) |
| MK-677 | $50 - $100/mo | Phase 2 |
| Ipamorelin | $35 - $70/mo | Category 2 (pending reclassification) |
| GHRP-6 | $35 - $70/mo | Not submitted |
| Sermorelin | $150 - $350/mo | Withdrawn (off-label use continues) |
Where to get CJC-1295
Prescription telehealth partners - see pricing and eligibility.
PeptideVS may earn a commission from providers listed below. Our editorial data is independent - see our disclosure for details.
Eden
Sponsored
Research peptide telehealth covering recovery, longevity, and growth-hormone protocols.
- Non-GLP-1 peptide catalog (GHRH, healing, longevity)
- Licensed prescriber intake, US pharmacy fulfillment
- Multi-peptide stacks available
We may earn a commission when you sign up.
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy or medication. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary.